Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis

BACKGROUND: Multiple therapies including immune-checkpoint inhibitors are emerging as effective treatment for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC). However, the optimal first-line and second-line treatments remains controversial. METHODS: We systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Zhe, Zhang, Bin, Zhang, Lu, Huang, Wenhui, Mo, Xiaokai, Chen, Qiuyin, Wang, Fei, Chen, Zhuozhi, Li, Minmin, Zhang, Shuixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768319/
https://www.ncbi.nlm.nih.gov/pubmed/33488783
http://dx.doi.org/10.1177/1758835920983717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768319/
https://www.ncbi.nlm.nih.gov/pubmed/33488783
http://dx.doi.org/10.1177/1758835920983717

Ejemplares similares